股市新闻
最新财经新闻 · 更新于 七月 18, 2026
Medicus Pharma Ltd. (MDCXW) 报告 FDA 进展并扩大 2026 年临床前景
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook
Medicus Pharma (MDCXW) faces acute financing pressure with only 2 quarters of runway, despite recent clinical progress. Dilution is likely …
MicroVision, Inc. (MVIS) 与 Avular 合作推进自主无人机系统
MicroVision, Inc. (MVIS) Partners With Avular to Advance Autonomous Drone Systems
The panel is bearish on MicroVision (MVIS) due to high execution risk, lack of binding commitments, and intense competition in …
是远景未来智能电动公司 (FFAI) 在 2026 年成为值得关注的人工智能机器人股票吗？
Is Faraday Future Intelligent Electric Inc. (FFAI) Emerging as an AI Robotics Stock to Watch in 2026?
The panel consensus is overwhelmingly bearish on FFAI's current trajectory, citing microscopic revenue, heavy cash burn, and questionable execution capabilities …
Cycurion, Inc. (CYCU) 是否将成为 2026 年高利润率的网络安全增长股？
Is Cycurion, Inc. (CYCU) Emerging as a High-Margin Cybersecurity Growth Stock in 2026?
The panel consensus is bearish on CYCU, with the main takeaway being that the company's bullish revenue visibility narrative relies …
没有太多英伟达？这家半导体ETF没问题
Not Much Nvidia? It's No Problem for This Semiconductor ETF
The panel discusses the outperformance of XSD, an equal-weighted semiconductor ETF, with mixed views on its sustainability and risks. While …
Lake Street 将 Cardlytics, Inc. (CDLX) 目标价下调至 1.25 美元，因预期重置
Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations
The panel consensus is that CDLX is in a dire financial situation, with significant revenue declines, negative free cash flow, …
为什么 Humacyte, Inc. (HUMA) 的目标价被提高，尽管处于早期商业化阶段
Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization
The panel consensus is bearish on Humacyte's stock, with concerns about heavy cash burn, negligible revenue, and uncertainty around strategic …
为什么赫朗医药公司 (HRTX) 的目标价被降低至 4 美元？H.C. Wainwright 的分析
Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?
The panelists agree that Heron Therapeutics' (HRTX) financial outlook is uncertain, with a key risk being the slow adoption of …
能否在 Baird 调整目标价后，Definitive Healthcare Corp. (DH) 维持稳定？
Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?
The panel consensus is bearish, with concerns about Definitive Healthcare's (DH) revenue contraction and uncertainty around its customer retention and …
渣打银行将收购 Zodia Custody
Standard Chartered to acquire Zodia Custody
Standard Chartered's deal to fold Zodia Custody into its core business and spin out Zodia Solutions as a multi-bank backed …
晨间关注：停火悬于一线
Morning Bid: Ceasefire on a knife edge
Despite Trump's Iran de-escalation comments, markets remain cautious due to structural oil supply tightness and potential energy inflation. The NextEra-Dominion …
分析师认为 Boost Run (BRUN) 的增长故事可能才刚刚开始
Why Analysts Believe Boost Run’s (BRUN) Growth Story May Still Be Early
Panelists largely agree that BRUN's recent analyst upgrades are overhyped, with significant execution risks and potential market headwinds outweighing the …